My WebLink
|
Help
|
About
|
Sign Out
Home
RES 521 Draft 01 2006-2008
ClerkCouncil
>
Council Records
>
Resolutions
>
2006-2008
>
RES 521 Draft 01 2006-2008
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/16/2009 3:20:55 PM
Creation date
5/8/2008 6:59:03 PM
Metadata
Fields
Template:
Bill/Resolution
Bill/Resolution - Type
RES
Bill/Resolution - Council Term
2006-2008
Bill/Resolution
521
Draft
01
Introducer
Bob Jacobson, Councilmember
Referred To
FC
Action 1
FC-247: Recommends adoption of Res. 521-08 - 2/5/08
Action 2
Council: Adopts Res. 521-08 & FC-247- 2/21/08
Status
Adopted
Date To Mayor or Adoption Date
2/21/2008
Reading Number
1
Reading Date
2/21/2008
Ayes
8-Ford; Higa; Hoffmann; Jacobson; Naeole; Pilago; Yagong; Yoshimoto
Noes
0-
Absent
1-Ikeda
Excused
0-
Document Relationships
AGE COUNCIL 2008/02/21 2006-2008
(Related)
Path:
\Council Records\Agendas\2006-2008\Council
AGE FC 02/05/2008 2006-2008
(Related)
Path:
\Council Records\Agendas\2006-2008\Finance Committee (FC)
REP FC 247 02/05/2008 2006-2008
(Related To)
Path:
\Council Records\Reports\2006-2008\Finance Committee (FC)
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
34
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
medications. These programs may include mailings to Participants with active prescriptions for targeted drug <br /> products or drug classes or to let Participants know that they may qualify for participation in a clinical trial <br /> program. Such mailings may include Participant and drug specific information andlor general educational <br /> material. Participants, by notifying Cazemazk, may opt-out of such programs. <br /> b. DUR Services. Caremark will provide its automated concurrent DUR Services for Claims. <br /> The information generated in connection with DUR Services is intended as an economical supplement to, and <br /> not as a substitute for, the knowledge, expertise, skill, and judgment of physicians, pharmacists, or other health <br /> caze providers in providing patient care. Providers aze individually responsible far acting or not acting upon <br /> information generated and transmitted through the DUR Services, and for performing services in each <br /> jurisdiction consistent with the scope of their licenses. Notwithstanding anything set forth in this Agreement, <br /> Caremazk will have no obligation to acquire information concerning any Participant beyond the information <br /> that is included in Caremark's eligibility records or the Claims submitted by Participating Pharmacies in <br /> connection with the Consumer Cazd Program. <br /> 1.8 Formulary Services. Caremark will administer an open formulary for the Member County and will <br /> provide certain Services that aze designed to provide useful clinical information to physiciams (the "Formulary <br /> Services"). Caremark may make changes to the Formulary Services described in this Agreement from time to time, and <br /> will notify Member County and Customer of any material changes to any formulary management programs. In all <br /> cases, the prescribing physician shall have final authority over the drug that is prescribed to the Participant. <br /> a. Rebate Contracts. Caremark contracts with certain Manufacturers for Rebate programs. <br /> b. Disclosure of Manufacturer Fees. Caremark may receive fees or other compensation from <br /> Manufacturers, including, without limitation, administrative fees not exceeding three percent of the aggregate <br /> cost of the pharmaceutical products dispensed to participants, and fees for property provided or services <br /> remdered to a Manufacturer (which may include providing physicians clinical messages consistent with the <br /> Performance Drug List, as defined below). Cazemazk's specialty pharmacies may also receive fees from <br /> Manufacturers for products and services provided. In addition, Cazemazk's mail order and specialty <br /> pharmacies may negotiate on their own behalf directly with Manufacturers for discounts, including rebated <br /> discounts based on mazket shaze or other factors. The teen Rebates as used in this Agreement does not include <br /> these fees and discounts which belong exclusively to Caremark or Cazemazk's mail order or specialty <br /> pharmacies, respectively. <br /> c. Participant Authorizations and Disclosures. Customer and Member County shall comply <br /> with all Laws applicable to it as a sponsor of the Services or as otherwise consistent with its obligations under <br /> this Agreement. <br /> d. Additional Participant Discounts. Cazemark may provide a program that will provide <br /> Participants with additional manufacturer discoants on certain drugs at the point of sale. From time to time, <br /> Caremark may revise the list of drugs that have additional participant discounts. The current list of drugs on <br /> which Participants may receive additional discounts is available upon request. Cazemark will timely notify <br /> Member County and Customer of any revisions to this list of drugs. <br /> 1.4 Management Reports. Caremark will provide Member County and Customer with Caremazk's <br /> standard management reports in connection with the Services, which reports may change from time to time at <br /> Caremark's discretion. Member County and Customer may elect to receive a reasonable number of the standard <br /> management reports made available by Caremark, <br /> 1.10 Mail Service Program. Cazemazk may provide to Member County mail order pharmacy services <br /> through its mail order pharmacy facilities. For the duration of this Agreement, Member County agrees that it will offer <br /> only Caremazk mail order pharmacy services for its Participants covered under this Agreement, as further described <br /> below. <br /> Caremark shall fill prescriptions for Participants and shall mail such drugs or medications to such Participants subject to <br /> the following terms and conditions: <br /> <br /> NACo k3-v2.doc (02/2412006) (RzClaiml Page 2 of29 <br /> This document contains proprietary information of Caremark, and may not be used for any pupose other than t0 evaluate entering into a relationship <br /> with Caremark, nor may it be duplicated or disclosed to others for any purpose. <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.